Literature DB >> 21630136

Prion protein and its conformational conversion: a structural perspective.

Witold K Surewicz1, Marcin I Apostol.   

Abstract

The key molecular event in the pathogenesis of prion diseases is the conformational conversion of a cellular prion protein, PrP(C), into a misfolded form, PrP(Sc). In contrast to PrP(C) that is monomeric and α-helical, PrP(Sc) is oligomeric in nature and rich in β-sheet structure. According to the "protein-only" model, PrP(Sc) itself represents the infectious prion agent responsible for transmissibility of prion disorders. While this model is supported by rapidly growing experimental data, detailed mechanistic and structural aspects of prion protein conversion remain enigmatic. In this chapter we describe recent advances in understanding biophysical and biochemical aspects of prion diseases, with a special focus on structural underpinnings of prion protein conversion, the structural basis of prion strains, and generation of prion infectivity in vitro from bacterially-expressed recombinant PrP.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21630136     DOI: 10.1007/128_2011_165

Source DB:  PubMed          Journal:  Top Curr Chem        ISSN: 0340-1022


  32 in total

1.  Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions.

Authors:  Nathan R Deleault; Daniel J Walsh; Justin R Piro; Fei Wang; Xinhe Wang; Jiyan Ma; Judy R Rees; Surachai Supattapone
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-18       Impact factor: 11.205

Review 2.  Probing the role of structural features of mouse PrP in yeast by expression as Sup35-PrP fusions.

Authors:  Lyne Jossé; Ricardo Marchante; Jo Zenthon; Tobias von der Haar; Mick F Tuite
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

3.  Transformation: the next level of regulation.

Authors:  Stefan H Knauer; Paul Rösch; Irina Artsimovitch
Journal:  RNA Biol       Date:  2012-11-06       Impact factor: 4.652

4.  Creationism and evolutionism in prions.

Authors:  Pierluigi Gambetti
Journal:  Am J Pathol       Date:  2013-02-01       Impact factor: 4.307

5.  An α helix to β barrel domain switch transforms the transcription factor RfaH into a translation factor.

Authors:  Björn M Burmann; Stefan H Knauer; Anastasia Sevostyanova; Kristian Schweimer; Rachel A Mooney; Robert Landick; Irina Artsimovitch; Paul Rösch
Journal:  Cell       Date:  2012-07-20       Impact factor: 41.582

6.  Biophysical and morphological studies on the dual interaction of non-octarepeat prion protein peptides with copper and nucleic acids.

Authors:  Juliana A P Chaves; Carolina Sanchez-López; Mariana P B Gomes; Tháyna Sisnande; Bruno Macedo; Vanessa End de Oliveira; Carolina A C Braga; Luciana P Rangel; Jerson L Silva; Liliana Quintanar; Yraima Cordeiro
Journal:  J Biol Inorg Chem       Date:  2014-02-21       Impact factor: 3.358

7.  Conformational stability of mammalian prion protein amyloid fibrils is dictated by a packing polymorphism within the core region.

Authors:  Nathan J Cobb; Marcin I Apostol; Shugui Chen; Vytautas Smirnovas; Witold K Surewicz
Journal:  J Biol Chem       Date:  2013-12-12       Impact factor: 5.157

8.  Amyloid fibrils from the N-terminal prion protein fragment are infectious.

Authors:  Jin-Kyu Choi; Ignazio Cali; Krystyna Surewicz; Qingzhong Kong; Pierluigi Gambetti; Witold K Surewicz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-14       Impact factor: 11.205

9.  Protein-solvent interfaces in human Y145Stop prion protein amyloid fibrils probed by paramagnetic solid-state NMR spectroscopy.

Authors:  Darryl Aucoin; Yongjie Xia; Theint Theint; Philippe S Nadaud; Krystyna Surewicz; Witold K Surewicz; Christopher P Jaroniec
Journal:  J Struct Biol       Date:  2018-04-18       Impact factor: 2.867

10.  Structural attributes of mammalian prion infectivity: Insights from studies with synthetic prions.

Authors:  Qiuye Li; Fei Wang; Xiangzhu Xiao; Chae Kim; Jen Bohon; Janna Kiselar; Jiri G Safar; Jiyan Ma; Witold K Surewicz
Journal:  J Biol Chem       Date:  2018-10-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.